News stories about Burcon NutraScience Corp (NASDAQ:BUR) (TSE:BU) have trended somewhat positive recently, according to Accern. The research group identifies positive and negative news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Burcon NutraScience Corp earned a news impact score of 0.24 on Accern’s scale. Accern also gave press coverage about the biotechnology company an impact score of 44.7122773295495 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
Separately, ValuEngine upgraded Burcon NutraScience Corp from a “strong sell” rating to a “sell” rating in a report on Wednesday, June 7th.
Burcon NutraScience Corp (NASDAQ:BUR) traded down 9.58% during midday trading on Monday, hitting $0.66. The stock had a trading volume of 2,165 shares. The company’s market cap is $24.97 million. The firm’s 50-day moving average price is $1.02 and its 200 day moving average price is $1.37. Burcon NutraScience Corp has a 12 month low of $0.66 and a 12 month high of $2.86.
Burcon NutraScience Corp Company Profile
Burcon NutraScience Corp (Burcon) is a Canada-based company, which is engaged in development of functional and renewable plant proteins. The Company has developed a portfolio of composition, application and process patents originating from a core protein extraction and purification technology. The Company and its subsidiary have developed CLARISOY, a soy protein; and are developing Peazazz, a pea protein, and Puratein, Supertein and Nutratein, approximately three canola protein isolates.
Receive News & Ratings for Burcon NutraScience Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Burcon NutraScience Corp and related companies with MarketBeat.com's FREE daily email newsletter.
